BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35765034)

  • 1. Genome analysis and virulence gene expression profile of a multi drug resistant Salmonella enterica serovar Typhimurium ms202.
    Mohakud NK; Panda RK; Patra SD; Sahu BR; Ghosh M; Kushwaha GS; Misra N; Suar M
    Gut Pathog; 2022 Jun; 14(1):28. PubMed ID: 35765034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Draft genome of clinical isolate Salmonella enterica Typhimurium ms204 from Odisha, India, reveals multi drug resistance and decreased virulent gene expression.
    Kumar Panda R; Darshana Patra S; Kumar Mohakud N; Ranjan Sahu B; Ghosh M; Misra N; Suar M
    Gene; 2023 May; 863():147248. PubMed ID: 36738898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome sequencing and analysis of
    Ashari KS; Roslan NS; Omar AR; Bejo MH; Ideris A; Mat Isa N
    PeerJ; 2019; 7():e6948. PubMed ID: 31293824
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Phenotype and Genotype Virulence and Antimicrobial Factors of
    Pławińska-Czarnak J; Wódz K; Guzowska M; Rosiak E; Nowak T; Strzałkowska Z; Kwieciński A; Kwieciński P; Anusz K
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982209
    [No Abstract]   [Full Text] [Related]  

  • 5. Spatial segregation of virulence gene expression during acute enteric infection with Salmonella enterica serovar Typhimurium.
    Laughlin RC; Knodler LA; Barhoumi R; Payne HR; Wu J; Gomez G; Pugh R; Lawhon SD; Bäumler AJ; Steele-Mortimer O; Adams LG
    mBio; 2014 Feb; 5(1):e00946-13. PubMed ID: 24496791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Approaches for Understanding the Characteristics of
    Kim S; Kim E; Park S; Hahn TW; Yoon H
    J Microbiol Biotechnol; 2017 Nov; 27(11):1983-1993. PubMed ID: 29032651
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrinsic insights to antimicrobial effects of Nitrofurantoin to multi drug resistant Salmonella enterica serovar Typhimurium ms202.
    Mohakud NK; Panda RK; Singh D; Patra SD; Simnani FZ; Sinha A; Nandi A; Jha E; Singh S; Kaushik NK; Panda PK; Singh D; Verma SK; Suar M
    Biomed Pharmacother; 2023 Sep; 165():115180. PubMed ID: 37454596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Type III Secretion System Effector SeoC of Salmonella enterica subsp. salamae and S. enterica subsp. arizonae ADP-Ribosylates Src and Inhibits Opsonophagocytosis.
    Pollard DJ; Young JC; Covarelli V; Herrera-León S; Connor TR; Fookes M; Walker D; Echeita A; Thomson NR; Berger CN; Frankel G
    Infect Immun; 2016 Dec; 84(12):3618-3628. PubMed ID: 27736780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of salmonella pathogenicity island-2 type III secretion system effectors involved in intramacrophage replication of S. enterica serovar typhimurium: implications for rational vaccine design.
    Figueira R; Watson KG; Holden DW; Helaine S
    mBio; 2013 Apr; 4(2):e00065. PubMed ID: 23592259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the expression of SPI-1 genes pathogenicity and epidemiology between the emerging Salmonella enterica serovar Infantis and the model Salmonella enterica serovar Typhimurium.
    Aviv G; Cornelius A; Davidovich M; Cohen H; Suwandi A; Galeev A; Steck N; Azriel S; Rokney A; Valinsky L; Rahav G; Grassl GA; Gal-Mor O
    J Infect Dis; 2019 Aug; 220(6):1071-1081. PubMed ID: 31062854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmonella enterica Serovar Typhimurium SPI-1 and SPI-2 Shape the Global Transcriptional Landscape in a Human Intestinal Organoid Model System.
    Lawrence AE; Abuaita BH; Berger RP; Hill DR; Huang S; Yadagiri VK; Bons B; Fields C; Wobus CE; Spence JR; Young VB; O'Riordan MX
    mBio; 2021 May; 12(3):. PubMed ID: 34006652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation between pathogenic serovars within Salmonella pathogenicity islands.
    Amavisit P; Lightfoot D; Browning GF; Markham PF
    J Bacteriol; 2003 Jun; 185(12):3624-35. PubMed ID: 12775700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myricetin inhibits the type III secretion system of Salmonella enterica serovar typhimurium by downregulating the Salmonella pathogenic island I gene regulatory pathway.
    Lv Q; Lv Y; Dou X; Wassy SL; Jia G; Wei L; Yu Q; Deng X; Zhang C; Wang J
    Microb Pathog; 2021 Jan; 150():104695. PubMed ID: 33418000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic characterization of endemic Salmonella enterica serovar Typhimurium and Salmonella enterica serovar I 4,[5],12:i:- isolated in Malaysia.
    Ngoi ST; Yap KP; Thong KL
    Infect Genet Evol; 2018 Aug; 62():109-121. PubMed ID: 29684710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of the salmonella Fis regulon and its regulatory mechanism on pathogenicity islands.
    Wang H; Liu B; Wang Q; Wang L
    PLoS One; 2013; 8(5):e64688. PubMed ID: 23717649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role in virulence and protective efficacy in pigs of Salmonella enterica serovar Typhimurium secreted components identified by signature-tagged mutagenesis.
    Carnell SC; Bowen A; Morgan E; Maskell DJ; Wallis TS; Stevens MP
    Microbiology (Reading); 2007 Jun; 153(Pt 6):1940-1952. PubMed ID: 17526851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance Mechanism and Physiological Effects of Microcin Y in Salmonella enterica subsp.
    Han Y; Li Y; Zeng Z; Li W; Feng S; Cao W
    Microbiol Spectr; 2022 Dec; 10(6):e0185922. PubMed ID: 36453909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small molecule, C
    Boonyom R; Roytrakul S; Thinwang P
    J Genet Eng Biotechnol; 2022 Apr; 20(1):54. PubMed ID: 35380331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QseC mediates Salmonella enterica serovar typhimurium virulence in vitro and in vivo.
    Moreira CG; Weinshenker D; Sperandio V
    Infect Immun; 2010 Mar; 78(3):914-26. PubMed ID: 20028809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-genome analysis of Salmonella enterica serovar Typhimurium T000240 reveals the acquisition of a genomic island involved in multidrug resistance via IS1 derivatives on the chromosome.
    Izumiya H; Sekizuka T; Nakaya H; Taguchi M; Oguchi A; Ichikawa N; Nishiko R; Yamazaki S; Fujita N; Watanabe H; Ohnishi M; Kuroda M
    Antimicrob Agents Chemother; 2011 Feb; 55(2):623-30. PubMed ID: 21098248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.